Domov › Melanóm › New York

Klinické štúdie Melanóm v štáte New York

50 štúdií pre Melanóm hľadá účastníkov v zariadeniach v štáte New York.

Mestá v štáte New York

Oficiálny text štúdie (anglicky)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

New York Oncology Hematology, Albany

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06246916

Pan-tumor MRD Study

Guthrie Lourdes Memorial Hospital (GLMH), Binghamton
New York Cancer & Blood Specialists, Shirley

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Roswell Park Cancer Institute, Buffalo
Glens Falls Hospital, Glens Falls
NYU Langone Hospital - Long Island, Mineola
a 4 ďalších

Prebieha náborFáza 3

Vek 75 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07068074

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07339176

Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

Weill Cornell Medicine, New York

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07661966

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT04752826

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0142, Buffalo
Local Institution - 0170, New York
Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07492680

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT05607095

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

START Cancer Research New York-Long Island, Lake Success

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07287917

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06284590

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
a 1 ďalších

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05837767

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NYU Langone, New York

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT04913285

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Memorial Sloan Kettering Hospital, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07070232

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Prebieha náborFáza 1/2

12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
a 12 ďalších

Prebieha náborObservačná štúdia

Do veku 25 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT02402244

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

NYU Langone Health, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT07504796

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT06425926

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT05859074

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
a 1 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Roswell Park Cancer Institute, Buffalo

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT06150664

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Memorial Sloan Kettering (Melanoma/NSCLC), New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 7. 2026 · NCT06060613

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Call for Information (Investigational Site 0031), New York

Prebieha náborFáza 1/2

6 Months – 17 Years · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT02332668

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Weill Medical College of Cornell University, New York
Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 1/2

Vek 18 až 70 · Všetky pohlavia · Aktualizované 11. 6. 2026 · NCT05361174

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA04-0, New York

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06953089

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Perlmutter Cancer Center at NYU Langone Health, New York
Memorial Sloan-Kettering Cancer Center, New York
Columbia University, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 5. 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
Northwell Health Cancer Institute, New York

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Northwell Health, Lake Success

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT06413680

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Roswell Park, Buffalo
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
Columbia University Medical Center, New York
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 4. 2026 · NCT06326411

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 2/3

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 4. 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Glens Falls Hospital, Glens Falls
Queens Hospital Center, Jamaica
Montefiore Medical Center-Einstein Campus, The Bronx
a 1 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Northwell Health Cancer Institute - Zuckerberg Cancer Center, Lake Success
Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 2. 2026 · NCT05549297

ACTengine® IMA203 Combined With mRNA-4203

Memorial Sloan Kettering Cancer Center, New York

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 1. 2026 · NCT06946225

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.